Cerevel is a Massachusetts based biotechnology company that develops and commercializes investigational therapies for the treatment of neuroscience diseases.Read more
$ < 1M
Cerevel Therapeutics's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 12.3B. Over the last three quarters, Cerevel Therapeutics's revenue has decreased by 88.1%. Specifically, in Q2 2021's revenue was $ < 1M; in Q1 2021, it was $ < 1M; in Q3 2020, it was $ < 1M.